However, in gastric adenocarcinoma, RNASET2 expression was shown to have no significant correlation with angiogenesis, lymph node metastasis or patient prognosis, despite being significantly downregulated relative to normal tissue [11]. The gene discussed is RNASET2; the disease is metastatic malignant neoplasm in the lymph nodes.